Altman JK - Search Results

1

Dual targeting of acute myeloid leukemia progenitors by catalytic mTOR inhibition and blockade of the p110α subunit of PI3 kinase.

Colamonici M, Blyth G, Saleiro D, Szilard A, Bliss-Moreau M, Giles FJ, Altman JK, Beauchamp EM, Platanias LC. Colamonici M, et al. Among authors: altman jk. Oncotarget. 2015 Apr 10;6(10):8062-70. doi: 10.18632/oncotarget.3509. Oncotarget. 2015. PMID: 25823922 Free PMC article.

2

Role of the p38 mitogen-activated protein kinase pathway in cytokine-mediated hematopoietic suppression in myelodysplastic syndromes.

Katsoulidis E, Li Y, Yoon P, Sassano A, Altman J, Kannan-Thulasiraman P, Balasubramanian L, Parmar S, Varga J, Tallman MS, Verma A, Platanias LC. Katsoulidis E, et al. Cancer Res. 2005 Oct 1;65(19):9029-37. doi: 10.1158/0008-5472.CAN-04-4555. Cancer Res. 2005. PMID: 16204077

3

Activation of mammalian target of rapamycin and the p70 S6 kinase by arsenic trioxide in BCR-ABL-expressing cells.

Yoon P, Giafis N, Smith J, Mears H, Katsoulidis E, Sassano A, Altman J, Redig AJ, Tallman MS, Platanias LC. Yoon P, et al. Mol Cancer Ther. 2006 Nov;5(11):2815-23. doi: 10.1158/1535-7163.MCT-06-0263. Mol Cancer Ther. 2006. PMID: 17121928

4

Suppressive effects of statins on acute promyelocytic leukemia cells.

Sassano A, Katsoulidis E, Antico G, Altman JK, Redig AJ, Minucci S, Tallman MS, Platanias LC. Sassano A, et al. Among authors: altman jk. Cancer Res. 2007 May 1;67(9):4524-32. doi: 10.1158/0008-5472.CAN-06-3686. Cancer Res. 2007. PMID: 17483369

5

Regulatory effects of mammalian target of rapamycin-mediated signals in the generation of arsenic trioxide responses.

Altman JK, Yoon P, Katsoulidis E, Kroczynska B, Sassano A, Redig AJ, Glaser H, Jordan A, Tallman MS, Hay N, Platanias LC. Altman JK, et al. J Biol Chem. 2008 Jan 25;283(4):1992-2001. doi: 10.1074/jbc.M705227200. Epub 2007 Nov 29. J Biol Chem. 2008. PMID: 18048359 Free article.

6

Suppression of programmed cell death 4 (PDCD4) protein expression by BCR-ABL-regulated engagement of the mTOR/p70 S6 kinase pathway.

Carayol N, Katsoulidis E, Sassano A, Altman JK, Druker BJ, Platanias LC. Carayol N, et al. Among authors: altman jk. J Biol Chem. 2008 Mar 28;283(13):8601-10. doi: 10.1074/jbc.M707934200. Epub 2008 Jan 26. J Biol Chem. 2008. PMID: 18223253 Free PMC article.

7

Regulation of arsenic trioxide-induced cellular responses by Mnk1 and Mnk2.

Dolniak B, Katsoulidis E, Carayol N, Altman JK, Redig AJ, Tallman MS, Ueda T, Watanabe-Fukunaga R, Fukunaga R, Platanias LC. Dolniak B, et al. Among authors: altman jk. J Biol Chem. 2008 May 2;283(18):12034-42. doi: 10.1074/jbc.M708816200. Epub 2008 Feb 25. J Biol Chem. 2008. PMID: 18299328 Free PMC article.

8

Exploiting the mammalian target of rapamycin pathway in hematologic malignancies.

Altman JK, Platanias LC. Altman JK, et al. Curr Opin Hematol. 2008 Mar;15(2):88-94. doi: 10.1097/MOH.0b013e3282f3deaa. Curr Opin Hematol. 2008. PMID: 18300753 Review.

9

Activation of protein kinase C{eta} by type I interferons.

Redig AJ, Sassano A, Majchrzak-Kita B, Katsoulidis E, Liu H, Altman JK, Fish EN, Wickrema A, Platanias LC. Redig AJ, et al. Among authors: altman jk. J Biol Chem. 2009 Apr 17;284(16):10301-14. doi: 10.1074/jbc.M807254200. Epub 2009 Feb 11. J Biol Chem. 2009. PMID: 19211565 Free PMC article.

10

Prospects for mTOR targeting in adult T cell leukemia.

Altman JK, Platanias LC. Altman JK, et al. Leuk Lymphoma. 2009 Apr;50(4):525-6. doi: 10.1080/10428190902741505. Leuk Lymphoma. 2009. PMID: 19373648 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

186 results

Search Page